|Articles|March 1, 2002

Applied Clinical Trials

  • Applied Clinical Trials-03-01-2002

Consider Geography When Choosing Investigative Sites

An essential aspect of selecting the location for an investigative site is the population surrounding it. Here is a method for determining how many potential subjects are available to your investigators.

Articles in this issue

over 24 years ago

9th ACT European Summit

over 24 years ago

Selecting Sites and Investigators

over 24 years ago

Letters to the Editor

over 24 years ago

Transporting Clinical Trial Samples

over 24 years ago

Forward to 2004 or Back to 1984?

Related to this article

The Next Evolution of Patient-Centered Trials Starts with Design
Decentralized trial success depends less on how far activities move away from sites than on matching each activity’s delivery model to participant burden, site readiness, and data integrity, using patient intelligence to decide where flexibility helps and where site-based care remains essential.
© putilov_denis - © putilov_denis - stock.adobe.com
Sponsors rigorously vet CROs for oncology expertise but rarely apply the same scrutiny to the IRB reviewing their trials, even though increasingly complex protocols require reviewers with substantive therapeutic knowledge, not just a rostered oncologist.